Both spontaneous Ins2+/- and streptozotocin-induced type I diabetes cause bone loss in young mice

Journal of Cellular Physiology

Volumn 228, Issue 4, 2013, Pages 689-695

  Coe, Lindsay M ^a   Zhang, Jing ^a   McCabe, Laura R ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; GLUCOSE; OSTEOCALCIN; RNA;

ADIPOSE TISSUE; ADOLESCENT DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE ATROPHY; BONE DENSITY; BONE LENGTH; BONE MARROW; CLINICAL FEATURE; CONTROLLED STUDY; CORTICAL BONE; DISEASE MODEL; FEMUR; GLUCOSE BLOOD LEVEL; GROWTH DISORDER; GROWTH PLATE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; MUSCLE MASS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; THICKNESS; TRABECULAR BONE;

ANIMALS; BLOOD GLUCOSE; BONE DENSITY; BONE RESORPTION; CARTILAGE; COLLAGEN TYPE II; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMUR; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCALCIN; OSTEOGENESIS; RNA;

MUS; RODENTIA;

EID: 84871698082     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24177     Document Type: Article

References (51)

1. Abdullah MA. 2005. Epidemiology of type I diabetes mellitus among Arab children. Saudi Med J 26:911-917.
2. ADA, 2006. The dangerous toll of idabetes. American Diabetes Association.
3. Al-Fifi SH. 2010. The relation of age to the severity of Type I diabetes in children. J Family Community Med 17:87-90.
4. Al-Mendalawi MD, Al-Herbish A. 2009. Prevalence of type 1 diabetes mellitus in Saudi Arabian children and adolescents. Saudi Med J 30:310; author reply 310-311.
5. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK. 2005. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210-2218.
6. Bianchi ML. 2007. Osteoporosis in children and adolescents. Bone 41:486-495.
7. Botolin S, McCabe LR. 2006. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss. J Cell Physiol 209:967-976.
8. Botolin S, McCabe LR. 2007. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148:198-205.
9. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. 2005. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 146:3622-3631.
10. Bredella MA, Fazeli PK, Miller KK, Misra M, Torriani M, Thomas BJ, Ghomi RH, Rosen CJ, Klibanski A. 2009. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 94:2129-2136.
11. Coe LM, Irwin R, Lippner D, McCabe LR. 2011. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. J Cell Physiol 226:477-483.
12. DeFronzo RA, Reasner C. 1994. The diabetes control and complications trial study: Implications for the diabetic foot. J Foot Ankle Surg 33:551-556.
13. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. 2000. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43:1528-1533.
14. Felner EI, Klitz W, Ham M, Lazaro AM, Stastny P, Dupont B, White PC. 2005. Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus. Pediatr Diabetes 6:213-220.
15. Fowlkes JL, Bunn RC, Liu L, Wahl EC, Coleman HN, Cockrell GE, Perrien DS, Lumpkin CK, Jr., Thrailkill KM. 2008. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 149:1697-1704.
16. Garofalo S, Vuorio E, Metsaranta M, Rosati R, Toman D, Vaughan J, Lozano G, Mayne R, Ellard J, Horton W, de Crombrugghe B. 1991. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci USA 88:9648-9652.
17. Goodman WG, Hori MT. 1984. Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33:825-831.
18. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR. 1998. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11:413-419.
19. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. 2006. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214-F222.
20. Hamilton J, Daneman D. 2002. Deteriorating diabetes control during adolescence: Physiological or psychosocial? J Pediatr Endocrinol Metab 15:115-126.
21. Herr RR, Reusser F. 1967. New antibacterial agent (U-24, 544) isolated from Streptomyces griseus. Appl Microbiol 15:1142-1144.
22. Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK. 2007. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling. Am J Physiol Endocrinol Metab 293:E1687-E1696.
23. Horcajada-Molteni MN, Chanteranne B, Lebecque P, Davicco MJ, Coxam V, Young A, Barlet JP. 2001. Amylin and bone metabolism in streptozotocin-induced diabetic rats. J Bone Miner Res 16:958-965.
24. Johnston AP, Campbell JE, Found JG, Riddell MC, Hawke TJ. 2007. Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo. Am J Physiol Cell Physiol 292:C1033-C1040.
25. Junod A, Lambert AE, Stauffacher W, Renold AE. 1969. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest 48:2129-2139.
26. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. 2000. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 23:295-303.
27. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I. 2002. Adipogenesis and aging: Does aging make fat go MAD? Exp Gerontol 37:757-767.
28. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. 1995. Bone loss and bone turnover in diabetes. Diabetes 44:775-782.
29. Krause MP, Riddell MC, Gordon CS, Imam SA, Cafarelli E, Hawke TJ. 2009. Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models. J Appl Physiol 106:1650-1659.
30. Kruczek M, Gruca A. 1990. Seasonal variations in male mice at the time of sexual maturation. Lab Anim 24:36-39.
31. Lopez MF, White NM, Randall CL. 2001. Alcohol tolerance and nicotine cross-tolerance in adolescent mice. Addict Biol 6:119-127.
32. Martin LM, McCabe LR. 2007. Type I diabetic bone phenotype is location but not gender dependent. Histochem Cell Biol 128:125-133.
33. McCabe LR. 2007. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343-1357.
34. McCabe L. 2009. Switching fat from the periphery to bone-Why in type I diabetes? Expert Rev Endocrinol Metab 4:203-207.
35. McCabe L, Zhang J, Raehtz S. 2011. Understanding the skeletal pathology of type 1 and 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr 21:187-206.
36. Motyl K, McCabe LR. 2009a. Streptozotocin, type I diabetes severity and bone. Biol Proced Online 11:296-315.
37. Motyl KJ, McCabe LR. 2009b. Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice. J Cell Physiol 218:376-384.
38. Motyl KJ, Botolin S, Irwin R, Appledorn DM, Kadakia T, Amalfitano A, Schwartz RC, McCabe LR. 2009. Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol 218:575-583.
39. Nombela-Arrieta C, Ritz J, Silberstein LE. 2011. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 12:126-131.
40. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M. 2002. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 109:525-532.
41. Rauner M, Sipos W, Pietschmann P. 2008. Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation. Age (Dordr) 30:273-282.
42. Rosen CJ, Bouxsein ML. 2006. Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43.
43. Sabin MA, Cameron FJ, Werther GA. 2009. Type 1 diabetes-Still the commonest form of diabetes in children. Aust Fam Physician 38:695-697.
44. Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM, Nyman JS, Wang X. 2009. Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res 24:1618-1627.
45. Slade JM, Coe LM, Meyer RA, McCabe LR. 2012. Human bone marrow adiposity is linked with serum lipid levels not T1-diabetes. J Diabetes Complications 26:1-9.
46. Szkudelski T. 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546.
47. Urban AD, Grey M. 2006. Type 1 diabetes. Nurs Clin North Am 41:513-530; vi.
48. Weghofer M, Karlic H, Haslberger A. 2001. Quantitative analysis of immune-mediated stimulation of tumor necrosis factor-alpha in macrophages measured at the level of mRNA and protein synthesis. Ann Hematol 80:733-736.
49. Xian CJ, Cool JC, Pyragius T, Foster BK. 2006. Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy. J Cell Biochem 99:1688-1704.
50. Yaguchi M, Nagashima K, Izumi T, Okamoto K. 2003. Neuropathological study of C57BL/6Akita mouse, type 2 diabetic model: Enhanced expression of alphaB-crystallin in oligodendrocytes. Neuropathology 23:44-50.
51. Yoshioka M, Kayo T, Ikeda T, Koizumi A. 1997. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46:887-894.